Molecular oncology tumor board in colorectal cancer: Bench to bedside to bench - The virtuous cycle of research

Oncology

Metastatic colorectal cancer

Practice teaching course by Excemed

Friday, Oct 13 - Saturday, Oct 14 2017

Genoa, Italy

Language

English

Registration status

Closed

Target audiences

Practicing clinicians who have an interest in understanding colorectal cancer biology and building individual competencies in the management of the disease.

Files

Final Programme brochure

Introduction

Access learning resources by clicking the Outcomes tab or scroll down to the Scientific Programme.

Overview

The goal of personalized medicine is to tailor treatments to the patient’s individual biologic profile. In oncology, this concept has been reinvigorated by major achievements in therapeutic and molecular diagnostics. The exponential growth in understanding colorectal cancer biology has led to recent advancements in therapeutic strategy and predictability of added value for patients. The integration of precision medicine into medical oncology is transforming treatment algorithms which may ultimately translate knowledge into daily clinical practice, while leading to a more collaborative disease management approach among disciplines.

Learning objectives

• Recapitulate colorectal cancer biology and select molecular tests of clinical relevance
• Evaluate biomarker-driven strategies and establish a “continuum of care” in patients with colorectal cancer
• Implement the design and interpretation of clinical trials in colorectal cancer

Scientific programme

Friday, 13 October 2017

SESSION I

09.15 Introduction
A. Sobrero (Italy)

09.30 L1: Management of advanced colorectal cancer VIDEO LECTURE
A. Sobrero (Italy)

10.00 L2: Molecular determinants for first-line treatment in mCRC VIDEO LECTURE
C.H. Köhne (Germany)
This lecture will be graphically recorded

10.30 L3: Second-line treatment and beyond in mCRC
A. Sobrero (Italy)
This lecture will be graphically recorded

11.00 Coffee Break

11.15 Working groups

Clinical cases solving
C.H. Köhne (Germany); F.S. Papadia (Italy); A. Sobrero (Italy)

12.45 Question time

13.00 Lunch

SESSION II

14.00 L4: Dominant molecular pathways in CRC VIDEO LECTURE
R. Dienstmann (Spain)

14.30 L5: Tumor heterogeneity VIDEO LECTURE
P. Gazzaniga (Italy)
This lecture will be graphically recorded

15.00 L6: Colorectal molecular subtypes and beyond VIDEO LECTURE
R. Dienstmann (Spain)

15.30 Coffee Break

15.45 L7: Tissue sampling bias and liquid biopsy
P. Gazzaniga (Italy)
This lecture will be graphically recorded

16.15 Question time

16.30 PATIENT MANAGEMENT
Molecular oncology & Medical oncology: interprofessional dialogues
R. Dienstmann (Spain); P. Gazzaniga (Italy);
C.H. Köhne (Germany); A. Sobrero (Italy)

17.15 End of the first day

Saturday, 14 October 2017

09.15 Wrap-up time

09.30 L8: Three versus six months adjuvant chemotherapy in stage III colon cancer
A. Sobrero (Italy)

10.00 L9: To treat or not to treat stage II CRC
C.H. Köhne (Germany)

10.30 Coffee Break

10.45 Working groups
Clinical cases solving
C.H. Köhne (Germany); F.S. Papadia (Italy); A. Sobrero (Italy)

11.15 L10: Evolving clinical trial design in CRC
R. Dienstmann (Spain)
This lecture will be graphically recorded

11.45 L11: Interpretation of clinical trials results
A. Sobrero (Italy)
This lecture will be graphically recorded

12.15 CLINICAL TRIALS
Molecular oncology & Medical oncology: interprofessional dialogues
R. Dienstmann (Spain); P. Gazzaniga (Italy);
C.H. Köhne (Germany); A. Sobrero (Italy)
This interprofessional dialogue will be graphically recorded

13.00 Concluding remarks

End of the course

Closing Lunch